Integrative analysis of genome-wide DNA methylation and single-nucleotide polymorphism identified ACSM5 as a suppressor of lumbar ligamentum flavum hypertrophy
Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing to an abnormal pressure on spinal nerves. Previous studies revealed HLF might be caused by fibrosis, inflammatory, and other bio-pathways. However, a gl...
Saved in:
Published in | Arthritis research & therapy Vol. 23; no. 1; pp. 251 - 16 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
30.09.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing to an abnormal pressure on spinal nerves. Previous studies revealed HLF might be caused by fibrosis, inflammatory, and other bio-pathways. However, a global analysis of HLF is needed severely.
A genome-wide DNA methylation and single-nucleotide polymorphism analysis were performed from five LDD patients with HLF and five LDD patients without HLF. Comprehensive integrated analysis was performed using bioinformatics analysis and the validated experiments including Sanger sequencing, methylation-specific PCR, qPCR and ROC analysis. Furthermore, the function of novel genes in ligamentum flavum cells (LFCs) was detected to explore the molecular mechanism in HLF through knock down experiment, overexpression experiment, CCK8 assay, apoptosis assay, and so on.
We identified 69 SNP genes and 735 661 differentially methylated sites that were enriched in extracellular matrix, inflammatory, and cell proliferation. A comprehensive analysis demonstrated key genes in regulating the development of HLF including ACSM5. Furthermore, the hypermethylation of ACSM5 that was mediated by DNMT1 led to downregulation of ACSM5 expression, promoted the proliferation and fibrosis, and inhibited the apoptosis of LFCs.
This study revealed that DNMT1/ACSM5 signaling could enhance HLF properties in vitro as a potential therapeutic strategy for HLF. |
---|---|
AbstractList | Background Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing to an abnormal pressure on spinal nerves. Previous studies revealed HLF might be caused by fibrosis, inflammatory, and other bio-pathways. However, a global analysis of HLF is needed severely. Methods A genome-wide DNA methylation and single-nucleotide polymorphism analysis were performed from five LDD patients with HLF and five LDD patients without HLF. Comprehensive integrated analysis was performed using bioinformatics analysis and the validated experiments including Sanger sequencing, methylation-specific PCR, qPCR and ROC analysis. Furthermore, the function of novel genes in ligamentum flavum cells (LFCs) was detected to explore the molecular mechanism in HLF through knock down experiment, overexpression experiment, CCK8 assay, apoptosis assay, and so on. Results We identified 69 SNP genes and 735 661 differentially methylated sites that were enriched in extracellular matrix, inflammatory, and cell proliferation. A comprehensive analysis demonstrated key genes in regulating the development of HLF including ACSM5. Furthermore, the hypermethylation of ACSM5 that was mediated by DNMT1 led to downregulation of ACSM5 expression, promoted the proliferation and fibrosis, and inhibited the apoptosis of LFCs. Conclusion This study revealed that DNMT1/ACSM5 signaling could enhance HLF properties in vitro as a potential therapeutic strategy for HLF. Keywords: Genome-wide DNA methylation, Single-nucleotide polymorphism, Hypertrophy of ligamentum flavum, ACSM5, Cell fibrosis Background Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing to an abnormal pressure on spinal nerves. Previous studies revealed HLF might be caused by fibrosis, inflammatory, and other bio-pathways. However, a global analysis of HLF is needed severely. Methods A genome-wide DNA methylation and single-nucleotide polymorphism analysis were performed from five LDD patients with HLF and five LDD patients without HLF. Comprehensive integrated analysis was performed using bioinformatics analysis and the validated experiments including Sanger sequencing, methylation-specific PCR, qPCR and ROC analysis. Furthermore, the function of novel genes in ligamentum flavum cells (LFCs) was detected to explore the molecular mechanism in HLF through knock down experiment, overexpression experiment, CCK8 assay, apoptosis assay, and so on. Results We identified 69 SNP genes and 735 661 differentially methylated sites that were enriched in extracellular matrix, inflammatory, and cell proliferation. A comprehensive analysis demonstrated key genes in regulating the development of HLF including ACSM5. Furthermore, the hypermethylation of ACSM5 that was mediated by DNMT1 led to downregulation of ACSM5 expression, promoted the proliferation and fibrosis, and inhibited the apoptosis of LFCs. Conclusion This study revealed that DNMT1/ACSM5 signaling could enhance HLF properties in vitro as a potential therapeutic strategy for HLF. Abstract Background Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing to an abnormal pressure on spinal nerves. Previous studies revealed HLF might be caused by fibrosis, inflammatory, and other bio-pathways. However, a global analysis of HLF is needed severely. Methods A genome-wide DNA methylation and single-nucleotide polymorphism analysis were performed from five LDD patients with HLF and five LDD patients without HLF. Comprehensive integrated analysis was performed using bioinformatics analysis and the validated experiments including Sanger sequencing, methylation-specific PCR, qPCR and ROC analysis. Furthermore, the function of novel genes in ligamentum flavum cells (LFCs) was detected to explore the molecular mechanism in HLF through knock down experiment, overexpression experiment, CCK8 assay, apoptosis assay, and so on. Results We identified 69 SNP genes and 735 661 differentially methylated sites that were enriched in extracellular matrix, inflammatory, and cell proliferation. A comprehensive analysis demonstrated key genes in regulating the development of HLF including ACSM5. Furthermore, the hypermethylation of ACSM5 that was mediated by DNMT1 led to downregulation of ACSM5 expression, promoted the proliferation and fibrosis, and inhibited the apoptosis of LFCs. Conclusion This study revealed that DNMT1/ACSM5 signaling could enhance HLF properties in vitro as a potential therapeutic strategy for HLF. Abstract Background Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing to an abnormal pressure on spinal nerves. Previous studies revealed HLF might be caused by fibrosis, inflammatory, and other bio-pathways. However, a global analysis of HLF is needed severely. Methods A genome-wide DNA methylation and single-nucleotide polymorphism analysis were performed from five LDD patients with HLF and five LDD patients without HLF. Comprehensive integrated analysis was performed using bioinformatics analysis and the validated experiments including Sanger sequencing, methylation-specific PCR, qPCR and ROC analysis. Furthermore, the function of novel genes in ligamentum flavum cells (LFCs) was detected to explore the molecular mechanism in HLF through knock down experiment, overexpression experiment, CCK8 assay, apoptosis assay, and so on. Results We identified 69 SNP genes and 735 661 differentially methylated sites that were enriched in extracellular matrix, inflammatory, and cell proliferation. A comprehensive analysis demonstrated key genes in regulating the development of HLF including ACSM5. Furthermore, the hypermethylation of ACSM5 that was mediated by DNMT1 led to downregulation of ACSM5 expression, promoted the proliferation and fibrosis, and inhibited the apoptosis of LFCs. Conclusion This study revealed that DNMT1/ACSM5 signaling could enhance HLF properties in vitro as a potential therapeutic strategy for HLF. Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing to an abnormal pressure on spinal nerves. Previous studies revealed HLF might be caused by fibrosis, inflammatory, and other bio-pathways. However, a global analysis of HLF is needed severely.BACKGROUNDHypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing to an abnormal pressure on spinal nerves. Previous studies revealed HLF might be caused by fibrosis, inflammatory, and other bio-pathways. However, a global analysis of HLF is needed severely.A genome-wide DNA methylation and single-nucleotide polymorphism analysis were performed from five LDD patients with HLF and five LDD patients without HLF. Comprehensive integrated analysis was performed using bioinformatics analysis and the validated experiments including Sanger sequencing, methylation-specific PCR, qPCR and ROC analysis. Furthermore, the function of novel genes in ligamentum flavum cells (LFCs) was detected to explore the molecular mechanism in HLF through knock down experiment, overexpression experiment, CCK8 assay, apoptosis assay, and so on.METHODSA genome-wide DNA methylation and single-nucleotide polymorphism analysis were performed from five LDD patients with HLF and five LDD patients without HLF. Comprehensive integrated analysis was performed using bioinformatics analysis and the validated experiments including Sanger sequencing, methylation-specific PCR, qPCR and ROC analysis. Furthermore, the function of novel genes in ligamentum flavum cells (LFCs) was detected to explore the molecular mechanism in HLF through knock down experiment, overexpression experiment, CCK8 assay, apoptosis assay, and so on.We identified 69 SNP genes and 735 661 differentially methylated sites that were enriched in extracellular matrix, inflammatory, and cell proliferation. A comprehensive analysis demonstrated key genes in regulating the development of HLF including ACSM5. Furthermore, the hypermethylation of ACSM5 that was mediated by DNMT1 led to downregulation of ACSM5 expression, promoted the proliferation and fibrosis, and inhibited the apoptosis of LFCs.RESULTSWe identified 69 SNP genes and 735 661 differentially methylated sites that were enriched in extracellular matrix, inflammatory, and cell proliferation. A comprehensive analysis demonstrated key genes in regulating the development of HLF including ACSM5. Furthermore, the hypermethylation of ACSM5 that was mediated by DNMT1 led to downregulation of ACSM5 expression, promoted the proliferation and fibrosis, and inhibited the apoptosis of LFCs.This study revealed that DNMT1/ACSM5 signaling could enhance HLF properties in vitro as a potential therapeutic strategy for HLF.CONCLUSIONThis study revealed that DNMT1/ACSM5 signaling could enhance HLF properties in vitro as a potential therapeutic strategy for HLF. Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing to an abnormal pressure on spinal nerves. Previous studies revealed HLF might be caused by fibrosis, inflammatory, and other bio-pathways. However, a global analysis of HLF is needed severely. A genome-wide DNA methylation and single-nucleotide polymorphism analysis were performed from five LDD patients with HLF and five LDD patients without HLF. Comprehensive integrated analysis was performed using bioinformatics analysis and the validated experiments including Sanger sequencing, methylation-specific PCR, qPCR and ROC analysis. Furthermore, the function of novel genes in ligamentum flavum cells (LFCs) was detected to explore the molecular mechanism in HLF through knock down experiment, overexpression experiment, CCK8 assay, apoptosis assay, and so on. We identified 69 SNP genes and 735 661 differentially methylated sites that were enriched in extracellular matrix, inflammatory, and cell proliferation. A comprehensive analysis demonstrated key genes in regulating the development of HLF including ACSM5. Furthermore, the hypermethylation of ACSM5 that was mediated by DNMT1 led to downregulation of ACSM5 expression, promoted the proliferation and fibrosis, and inhibited the apoptosis of LFCs. This study revealed that DNMT1/ACSM5 signaling could enhance HLF properties in vitro as a potential therapeutic strategy for HLF. Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing to an abnormal pressure on spinal nerves. Previous studies revealed HLF might be caused by fibrosis, inflammatory, and other bio-pathways. However, a global analysis of HLF is needed severely. A genome-wide DNA methylation and single-nucleotide polymorphism analysis were performed from five LDD patients with HLF and five LDD patients without HLF. Comprehensive integrated analysis was performed using bioinformatics analysis and the validated experiments including Sanger sequencing, methylation-specific PCR, qPCR and ROC analysis. Furthermore, the function of novel genes in ligamentum flavum cells (LFCs) was detected to explore the molecular mechanism in HLF through knock down experiment, overexpression experiment, CCK8 assay, apoptosis assay, and so on. We identified 69 SNP genes and 735 661 differentially methylated sites that were enriched in extracellular matrix, inflammatory, and cell proliferation. A comprehensive analysis demonstrated key genes in regulating the development of HLF including ACSM5. Furthermore, the hypermethylation of ACSM5 that was mediated by DNMT1 led to downregulation of ACSM5 expression, promoted the proliferation and fibrosis, and inhibited the apoptosis of LFCs. This study revealed that DNMT1/ACSM5 signaling could enhance HLF properties in vitro as a potential therapeutic strategy for HLF. |
ArticleNumber | 251 |
Audience | Academic |
Author | Duan, Yang Ni, Songjia Chen, Zhong Gong, Kaiqin Qiu, Sujun Cao, Yanlin Zhan, Yenan |
Author_xml | – sequence: 1 givenname: Yanlin surname: Cao fullname: Cao, Yanlin organization: Department of Spine Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China – sequence: 2 givenname: Yenan surname: Zhan fullname: Zhan, Yenan organization: Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China – sequence: 3 givenname: Sujun surname: Qiu fullname: Qiu, Sujun organization: Department of Spine Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China – sequence: 4 givenname: Zhong surname: Chen fullname: Chen, Zhong organization: Department of Spine Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China – sequence: 5 givenname: Kaiqin surname: Gong fullname: Gong, Kaiqin organization: Department of Spine Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China – sequence: 6 givenname: Songjia surname: Ni fullname: Ni, Songjia email: warriorkof@163.com organization: Department of Orthopaedic Trauma, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China. warriorkof@163.com – sequence: 7 givenname: Yang orcidid: 0000-0003-4809-9516 surname: Duan fullname: Duan, Yang email: duanxy@smu.edu.cn organization: Department of Spine Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China. duanxy@smu.edu.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34593020$$D View this record in MEDLINE/PubMed |
BookMark | eNptkstu1DAUhiNURNuBF2CBLLFhk-J77A3SaLiNVGABrC0nsTMeJXawk0HzNLwqTqeUFiHLsnX8nf_42P9lceaDN0XxHMErhAR_nRCBFSshRnlyzEr2qLhAtBIlJxyf3dufF5cp7SHEWGL6pDgnlEkCMbwofm39ZLqoJ3cwQHvdH5NLIFjQGR8GU_50rQFvP6_BYKbdsc9c8JlrQXK-603p56Y3YVqoMfTHIcRx59IAcsBPzjrTgvXm6ycGdAIapHkco0kpxKVEPw-1jqB3nR4yPQ_A9vqQl91xNHGKYdwdnxaPre6TeXa7rorv799923wsr7982G7W12XDOJlKayFvWYVRKypEa8wkE7yWpmJYM6lNLWqLDCassbxCrCGMC4QlIVAg3VBGVsX2pNsGvVdjdIOORxW0UzeBEDul4-RyswpBTqhExOKaUKKllEJTKbjFlBos2qz15qQ1zvVg2ib3FnX_QPThiXc71YWDElRgni-1Kl7dCsTwYzZpUoNLjel77U2Yk8KsEhUXkuKMvvwH3Yc55n9cKIElrSBCf6lO5wactyHXbRZRteaVgFBIXmXq6j9UHq0ZXJO9Z12OP0jAp4QmhpSisXc9IqgWi6qTRVW2qLqxqFpe-sX917lL-eNJ8huCn-QM |
CitedBy_id | crossref_primary_10_1186_s12967_022_03677_0 crossref_primary_10_1186_s13062_023_00383_9 crossref_primary_10_1016_j_arr_2022_101598 crossref_primary_10_1155_2022_1380353 crossref_primary_10_1155_2023_1164147 crossref_primary_10_1093_pm_pnac197 crossref_primary_10_1186_s13062_023_00436_z |
Cites_doi | 10.1007/BF01628891 10.1038/s41467-019-09984-3 10.1016/j.jep.2016.08.011 10.1016/j.tibs.2016.10.001 10.1038/s41388-018-0660-y 10.1371/journal.pone.0092633 10.22603/ssrr.2017-0007 10.2215/CJN.09100817 10.1007/s00586-017-5075-x 10.22603/ssrr.1.2017-0023 10.1096/fj.202000635R 10.3389/fcell.2020.00858 10.1016/j.pharmthera.2019.107416 10.1016/j.jos.2016.08.007 10.1161/JAHA.118.010089 10.1016/j.jphs.2015.03.008 10.1093/nar/gkg509 10.1089/omi.2011.0118 10.1007/978-1-4939-7481-8_23 10.1096/fj.202000494RR 10.1016/S0736-0266(02)00046-3 10.1186/1471-2474-15-238 10.1093/nar/gkf493 10.1038/ki.2014.305 10.1080/17425255.2016.1206888 10.7150/thno.32710 10.3109/03008207.2012.685132 10.1111/jcmm.15509 10.1227/NEU.0000000000000755 10.1371/journal.pone.0236197 10.3389/fmolb.2020.571641 10.3390/ma12020253 10.1002/jor.21431 10.1097/01.brs.0000263407.25009.6e 10.1016/j.pharmthera.2018.11.001 10.1681/ASN.2012100985 10.1159/000487574 10.1371/journal.pone.0128321 10.1161/CIRCRESAHA.120.316443 10.1016/j.genrep.2020.100992 10.3892/ijmm.2016.2631 10.1016/j.psychres.2019.112639 10.1007/s00467-020-04574-8 10.5435/JAAOS-D-15-00034 10.1016/S1047-9651(02)00063-3 10.4103/1947-2714.100998 10.1097/01.brs.0000231761.73859.2c |
ContentType | Journal Article |
Copyright | 2021. The Author(s). COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
Copyright_xml | – notice: 2021. The Author(s). – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13075-021-02625-5 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1478-6362 |
EndPage | 16 |
ExternalDocumentID | oai_doaj_org_article_10634913f2b343a9998a4986f244e28d A678008967 10_1186_s13075_021_02625_5 34593020 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: ; grantid: 81470121 |
GroupedDBID | --- -5E -5G -A0 -BR .GJ 0R~ 23N 2WC 3V. 4.4 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ ABUWG ACGFS ACJQM ACRMQ ADBBV ADINQ ADUKV AEGXH AENEX AFKRA AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK E3Z EBD EBLON ECM EIF EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE HZ~ IAO IHR INH INR ITC KQ8 M1P NPM O5R O5S O9- PGMZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SMD SOJ SV3 TR2 U2A UKHRP WOQ Z7U AAYXX AFPKN CITATION ABVAZ AFGXO AFNRJ ZA5 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c563t-ff06d5721d8714b259586b9e752a59aeb8bf1e235cf6715c356812933081ac453 |
IEDL.DBID | RPM |
ISSN | 1478-6362 1478-6354 |
IngestDate | Tue Oct 22 15:08:58 EDT 2024 Tue Sep 17 21:17:02 EDT 2024 Fri Aug 16 20:03:35 EDT 2024 Thu Oct 10 20:01:44 EDT 2024 Thu Feb 22 23:37:48 EST 2024 Wed Jan 10 04:19:25 EST 2024 Thu Sep 12 17:57:16 EDT 2024 Wed Oct 23 10:01:39 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | ACSM5 Single-nucleotide polymorphism Genome-wide DNA methylation Hypertrophy of ligamentum flavum Cell fibrosis |
Language | English |
License | 2021. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c563t-ff06d5721d8714b259586b9e752a59aeb8bf1e235cf6715c356812933081ac453 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4809-9516 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482693/ |
PMID | 34593020 |
PQID | 2582947011 |
PQPubID | 42876 |
PageCount | 16 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_10634913f2b343a9998a4986f244e28d pubmedcentral_primary_oai_pubmedcentral_nih_gov_8482693 proquest_miscellaneous_2578768942 proquest_journals_2582947011 gale_infotracmisc_A678008967 gale_infotracacademiconefile_A678008967 crossref_primary_10_1186_s13075_021_02625_5 pubmed_primary_34593020 |
PublicationCentury | 2000 |
PublicationDate | 2021-09-30 |
PublicationDateYYYYMMDD | 2021-09-30 |
PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-30 day: 30 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Arthritis research & therapy |
PublicationTitleAlternate | Arthritis Res Ther |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | JJ Munns (2625_CR2) 2015; 10 PL Tyack (2625_CR13) 2014; 9 XY Pan (2625_CR47) 2019; 9 PC Ng (2625_CR17) 2003; 31 X Qi (2625_CR43) 2019; 282 Z Zheng (2625_CR32) 2020; 8 NY Souren (2625_CR19) 2019; 10 Y Sakai (2625_CR3) 2017; 22 T Zhou (2625_CR35) 2018; 45 G Ozdemir (2625_CR39) 2020; 35 Z-M Zhong (2625_CR8) 2011; 29 T Nakatani (2625_CR12) 2002; 20 M Panagopoulou (2625_CR22) 2019; 38 A Unnikrishnan (2625_CR24) 2019; 195 MA Adams (2625_CR7) 2006; 31 T Fan (2625_CR30) 2020; 24 R van der Sluis (2625_CR40) 2016; 12 F Biancari (2625_CR16) 2018; 7 AF Malone (2625_CR37) 2014; 86 Y-H Chao (2625_CR10) 2012; 53 2625_CR11 Y Behnaz (2625_CR41) 2021; 22 2625_CR4 V Ramensky (2625_CR18) 2002; 30 T Mahmood (2625_CR23) 2012; 4 P Mehdipour (2625_CR25) 2020; 205 2625_CR1 C Sun (2625_CR27) 2020; 34 JR Gao (2625_CR44) 2016; 193 A Koseler (2625_CR45) 2020; 34 L Tian (2625_CR48) 2020; 126 MH Chen (2625_CR34) 2014; 15 H Storey (2625_CR38) 2013; 24 D Viejo-Fuertes (2625_CR5) 1998; 20 J Ramalho-Carvalho (2625_CR21) 1708; 2018 C Ma (2625_CR42) 2020; 7 JM Soll (2625_CR14) 2017; 42 N Chiba (2625_CR29) 2015; 127 H Zhu (2625_CR46) 2020; 34 2625_CR28 K Sairyo (2625_CR9) 2007; 32 P Wessberg (2625_CR26) 2017; 26 YL Cao (2625_CR31) 2016; 38 T Mori (2625_CR33) 2017; 1 GD Schroeder (2625_CR6) 2016; 24 YJ Choi (2625_CR15) 2020; 15 GC Yu (2625_CR20) 2012; 16 Y Wang (2625_CR36) 2018; 13 |
References_xml | – volume: 20 start-page: 171 issue: 3 year: 1998 ident: 2625_CR5 publication-title: Surg Radiol Anat doi: 10.1007/BF01628891 contributor: fullname: D Viejo-Fuertes – volume: 10 start-page: 2094 issue: 1 year: 2019 ident: 2625_CR19 publication-title: Nat Commun doi: 10.1038/s41467-019-09984-3 contributor: fullname: NY Souren – volume: 193 start-page: 140 year: 2016 ident: 2625_CR44 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2016.08.011 contributor: fullname: JR Gao – volume: 42 start-page: 206 issue: 3 year: 2017 ident: 2625_CR14 publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2016.10.001 contributor: fullname: JM Soll – volume: 38 start-page: 3387 issue: 18 year: 2019 ident: 2625_CR22 publication-title: Oncogene doi: 10.1038/s41388-018-0660-y contributor: fullname: M Panagopoulou – volume: 9 start-page: e92633 issue: 3 year: 2014 ident: 2625_CR13 publication-title: PLoS One doi: 10.1371/journal.pone.0092633 contributor: fullname: PL Tyack – ident: 2625_CR28 doi: 10.22603/ssrr.2017-0007 – volume: 13 start-page: 1162 issue: 8 year: 2018 ident: 2625_CR36 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.09100817 contributor: fullname: Y Wang – volume: 26 start-page: 2536 issue: 10 year: 2017 ident: 2625_CR26 publication-title: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society doi: 10.1007/s00586-017-5075-x contributor: fullname: P Wessberg – volume: 1 start-page: 211 issue: 4 year: 2017 ident: 2625_CR33 publication-title: Spine Surg Related Res doi: 10.22603/ssrr.1.2017-0023 contributor: fullname: T Mori – volume: 34 start-page: 9854 issue: 8 year: 2020 ident: 2625_CR27 publication-title: FASEB J doi: 10.1096/fj.202000635R contributor: fullname: C Sun – volume: 8 start-page: 858 year: 2020 ident: 2625_CR32 publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2020.00858 contributor: fullname: Z Zheng – volume: 205 start-page: 107416 year: 2020 ident: 2625_CR25 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2019.107416 contributor: fullname: P Mehdipour – volume: 22 start-page: 27 issue: 1 year: 2017 ident: 2625_CR3 publication-title: J Orthop Sci doi: 10.1016/j.jos.2016.08.007 contributor: fullname: Y Sakai – volume: 7 start-page: e010089 issue: 20 year: 2018 ident: 2625_CR16 publication-title: J Am Heart Assoc doi: 10.1161/JAHA.118.010089 contributor: fullname: F Biancari – volume: 127 start-page: 467 issue: 4 year: 2015 ident: 2625_CR29 publication-title: J Pharmacol Sci doi: 10.1016/j.jphs.2015.03.008 contributor: fullname: N Chiba – volume: 31 start-page: 3812 issue: 13 year: 2003 ident: 2625_CR17 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkg509 contributor: fullname: PC Ng – volume: 16 start-page: 284 issue: 5 year: 2012 ident: 2625_CR20 publication-title: Omics doi: 10.1089/omi.2011.0118 contributor: fullname: GC Yu – volume: 2018 start-page: 447 year: 1708 ident: 2625_CR21 publication-title: Methods Mol Biol doi: 10.1007/978-1-4939-7481-8_23 contributor: fullname: J Ramalho-Carvalho – volume: 34 start-page: 14558 issue: 11 year: 2020 ident: 2625_CR46 publication-title: FASEB J doi: 10.1096/fj.202000494RR contributor: fullname: H Zhu – volume: 20 start-page: 1380 issue: 6 year: 2002 ident: 2625_CR12 publication-title: J Orthop Res doi: 10.1016/S0736-0266(02)00046-3 contributor: fullname: T Nakatani – volume: 15 start-page: 238 issue: 1 year: 2014 ident: 2625_CR34 publication-title: BMC Musculoskelet Disord doi: 10.1186/1471-2474-15-238 contributor: fullname: MH Chen – volume: 30 start-page: 3894 issue: 17 year: 2002 ident: 2625_CR18 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkf493 contributor: fullname: V Ramensky – volume: 86 start-page: 1253 issue: 6 year: 2014 ident: 2625_CR37 publication-title: Kidney Int doi: 10.1038/ki.2014.305 contributor: fullname: AF Malone – volume: 12 start-page: 1169 issue: 10 year: 2016 ident: 2625_CR40 publication-title: Expert Opin Drug Metab Toxicol doi: 10.1080/17425255.2016.1206888 contributor: fullname: R van der Sluis – volume: 9 start-page: 4308 issue: 15 year: 2019 ident: 2625_CR47 publication-title: Theranostics doi: 10.7150/thno.32710 contributor: fullname: XY Pan – volume: 53 start-page: 422 issue: 5 year: 2012 ident: 2625_CR10 publication-title: Connect Tissue Res doi: 10.3109/03008207.2012.685132 contributor: fullname: Y-H Chao – volume: 24 start-page: 8753 issue: 15 year: 2020 ident: 2625_CR30 publication-title: J Cell Mol Med doi: 10.1111/jcmm.15509 contributor: fullname: T Fan – ident: 2625_CR11 doi: 10.1227/NEU.0000000000000755 – volume: 15 start-page: e0236197 issue: 7 year: 2020 ident: 2625_CR15 publication-title: PLoS One doi: 10.1371/journal.pone.0236197 contributor: fullname: YJ Choi – volume: 7 start-page: 571641 year: 2020 ident: 2625_CR42 publication-title: Front Mol Biosci doi: 10.3389/fmolb.2020.571641 contributor: fullname: C Ma – ident: 2625_CR1 doi: 10.3390/ma12020253 – volume: 29 start-page: 1592 issue: 10 year: 2011 ident: 2625_CR8 publication-title: J Orthop Res doi: 10.1002/jor.21431 contributor: fullname: Z-M Zhong – volume: 32 start-page: E340 issue: 11 year: 2007 ident: 2625_CR9 publication-title: Spine doi: 10.1097/01.brs.0000263407.25009.6e contributor: fullname: K Sairyo – volume: 195 start-page: 172 year: 2019 ident: 2625_CR24 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2018.11.001 contributor: fullname: A Unnikrishnan – volume: 24 start-page: 1945 issue: 12 year: 2013 ident: 2625_CR38 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2012100985 contributor: fullname: H Storey – volume: 45 start-page: 1472 issue: 4 year: 2018 ident: 2625_CR35 publication-title: Cell Physiol Biochem doi: 10.1159/000487574 contributor: fullname: T Zhou – volume: 10 start-page: e0128321 issue: 5 year: 2015 ident: 2625_CR2 publication-title: PLoS One doi: 10.1371/journal.pone.0128321 contributor: fullname: JJ Munns – volume: 126 start-page: 1723 issue: 12 year: 2020 ident: 2625_CR48 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.120.316443 contributor: fullname: L Tian – volume: 22 start-page: 100992 year: 2021 ident: 2625_CR41 publication-title: Gene Rep doi: 10.1016/j.genrep.2020.100992 contributor: fullname: Y Behnaz – volume: 38 start-page: 391 issue: 2 year: 2016 ident: 2625_CR31 publication-title: Int J Mol Med doi: 10.3892/ijmm.2016.2631 contributor: fullname: YL Cao – volume: 282 start-page: 112639 year: 2019 ident: 2625_CR43 publication-title: Psychiatry Res doi: 10.1016/j.psychres.2019.112639 contributor: fullname: X Qi – volume: 35 start-page: 1941 issue: 10 year: 2020 ident: 2625_CR39 publication-title: Pediatr Nephrol (Berlin, Germany) doi: 10.1007/s00467-020-04574-8 contributor: fullname: G Ozdemir – volume: 24 start-page: 843 issue: 12 year: 2016 ident: 2625_CR6 publication-title: J Am Acad Orthop Surg doi: 10.5435/JAAOS-D-15-00034 contributor: fullname: GD Schroeder – ident: 2625_CR4 doi: 10.1016/S1047-9651(02)00063-3 – volume: 4 start-page: 429 issue: 9 year: 2012 ident: 2625_CR23 publication-title: N Am J Med Sci doi: 10.4103/1947-2714.100998 contributor: fullname: T Mahmood – volume: 31 start-page: 2151 issue: 18 year: 2006 ident: 2625_CR7 publication-title: Spine doi: 10.1097/01.brs.0000231761.73859.2c contributor: fullname: MA Adams – volume: 34 start-page: 361 issue: 1 year: 2020 ident: 2625_CR45 publication-title: In Vivo (Athens, Greece) contributor: fullname: A Koseler |
SSID | ssj0022924 |
Score | 2.437689 |
Snippet | Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing to an... Abstract Background Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb... Background Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb numbness owing... Abstract Background Hypertrophy of ligamentum flavum (HLF) is a common lumbar degeneration disease (LDD) with typical symptoms of low back pain and limb... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 251 |
SubjectTerms | ACSM5 Analysis Arthritis Care and treatment Cell fibrosis Coenzyme A Ligases Collagen DNA (Cytosine-5-)-Methyltransferase 1 DNA methylation DNA Methylation - genetics Epigenetics Gene expression Genetic aspects Genome-wide DNA methylation Genomes Humans Hypertrophy - genetics Hypertrophy of ligamentum flavum Ligaments Ligamentum Flavum - metabolism Lumbar Vertebrae Older people Polymorphism Polymorphism, Single Nucleotide Single-nucleotide polymorphism Spinal diseases Spinal Stenosis - genetics Spinal Stenosis - metabolism Vertebrae |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gICMhcUARG79iH5dCVZDaC1TqzbITh0baTVZJlqq_pn-VGSe72ogDF04rxZNskm-ezvgzIe-1VAG_5qWQWptUFIGlPl_kaZBh4V0JOUMZG2Qv1Nml-H4lrw62-sKesJEeeHxxYNWKC5PxinkuuIN8RjthtKogLgWmy-h9M7krpqZSi0FZsVsio9WnHjx1jiuRoXRmkPGnchaGIlv_3z75ICjNGyYPItDpI_JwSh3pcrzlx-ReaJ6Q--fTx_Gn5O7bRP0ADoy6iWyEthVFHtZ1SG_qMtAvF0uKu0bfjj1wIFdSnC5YhbRBauN2QKlNu7pdtwBB3a9pXY4dRaGky5Mf55K6njrabzexh7bt8C_AxXnX0VX9y-F043ZNq5X7DT_XUOd2Q9cCms_I5enXnydn6bT_QlpIxYe0qhaqlFAillBVCQ9oSq28CblkThoXvPZVFhiXRaXyTBY8kpnhDInOXCEkf06OmrYJLwmteEDfAblZyEThjRGCA3gLBlfhivuEfNzBYTcjzYaN5YlWdgTPAng2gmdlQj4jYntJpMiOB0Bx7KQ49l-Kk5APiLdFQwZQCzetR4AbRkosu4QwDgmSUXlCjmeSYIDFfHinMXZyAL1lUjMjcvCeCXm3H8YzsamtCe0WZcBbKm0ES8iLUcH2j8SFNBxS-YTkM9WbPfN8pKmvIz24FlAyGv7qf7yk1-QBi1aDDTLH5GjotuENZGGDfxsN7g_8ZS3g priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0BfFF_G60ygqCD7L0sl_ZfZJrbalCi6iFvoXdZNMe3CVncqf0r_FfdSbZOxsEnw6yk0vCb753doaQt0bpgLt5DFxry2QROPPZJGNBhYl3JfgMZV8ge65PL-TnS3UZE25dLKvc6MReUZdNgTnyA64MtzIDdvyw_MFwahTursYRGnfJLk8lbtPuHh6ff_m6Dbm4HcbaSoiVwLTKzbEZow860N4Znk6GcJpDFMDUyDT1Hfz_1dO3DNW4iPKWVTp5SB5Ed5JOB_wfkTuhfkzuncUN8yfk96fYDgKUGnWxAQltKoq9WReB_ZqVgX48n1KcJH0z1MUBXUkxhTAPrMZ2x80KqZbN_GbRACyzbkFn5VBlFEo6Pfp2pqjrqKPdetnX1TYtPgLUnnctnc-uHKYg1wtazd1P-LmG2LddtQ0g_JRcnBx_PzplcSYDK5QWK1ZVE10qCBtLiLSkB4SV0d6GTHGnrAve-CoNXKii0lmqCtE3OMOsiUldIZV4Rnbqpg57hFYioD4Bfy2ksvDWSim4KScc_kVo4RPyfgNHvhxab-R9yGJ0PoCXA3h5D16uEnKIiG0psW12f6Fpr_IohXC7FtKmouJeSOHAOTZOWqMrcHICPDsh7xDvHIUbQC1cPKMAL4xtsvIpmHZwmqzOErI_ogShLMbLG47Jo1Lo8r8snJA322W8Ewvd6tCskQY0qDZW8oQ8Hxhs-0lCKivAvU9INmK90TePV-rZdd8y3EgII6148f_Xeknu814esBxmn-ys2nV4BT7Xyr-OgvUHLFsqRg priority: 102 providerName: ProQuest |
Title | Integrative analysis of genome-wide DNA methylation and single-nucleotide polymorphism identified ACSM5 as a suppressor of lumbar ligamentum flavum hypertrophy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34593020 https://www.proquest.com/docview/2582947011 https://www.proquest.com/docview/2578768942/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC8482693 https://doaj.org/article/10634913f2b343a9998a4986f244e28d |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZtB2MvY_d664IGgz0MN4lulh7TrKUbJJRtgbwZyZZbQ2wHJ2npr9lf3ZFsh5i97SWB6Ci2ORedI3_6DkKfJRfWvc0LIbVWIUssCU00ikLL7cjoFHKG1ANk5-J6wX4s-fII8e4sjAftJyY_L1fFeZnfeWzlukiGHU5seDObSgZJsaLDY3QcUdqV6G2VRVTTyZZBeQSrKetOykgx3EDAjtyBZKigCST-oetbQxlXdOT6fR8sTJ6__98ofbBM9SGUB2vS1Qv0vE0m8aS56ZfoyJav0NNZ-7r8NfrzvSWDgJCGdUs_gqsMO2bWwoYPeWrxt_kEuz7Sjw0qDuRS7DYQVjYsHdlxtXVS62r1WFSglHxT4DxtMEY2xZPprxnHeoM13uzWHlVb1e4SEPSMrvEqv9VuA3JX4Gyl7-HrDirfeltXoN83aHF1-Xt6HbYdGcKEC7oNs2wkUg5FYwp1FjOgXy6FUTbiRHOlrZEmG1tCeZKJaMwT6unN3J6JHOuEcfoWnZRVaU8Rzqh10QSyNTtmiVGKMUpkOiLwL1RQE6CvnTridUO8EfuCRYq40WMMeoy9HmMeoAunsb2kI832P1T1bdyaDkwXlKkxzYihjGpIjaVmSooMUhwL1w7QF6fv2Lk2KDXR7QkFuGFHkhVPYGGHlEmJKEBnPUlwyaQ_3FlM3IaETUy4JIpFEE8D9Gk_7GY6mFtpq52TgfgppGIkQO8aA9s_UmenAYp6ptd75v4I-I8nDG_95f1_z_yAnhHvNQ4nc4ZOtvXOfoRkbGsG4ILLaICeXFzOb34O_JbGwDskfC7I5C-wbTZK |
link.rule.ids | 230,315,733,786,790,870,891,2115,12083,21416,27955,27956,31752,31753,33777,33778,43343,43838,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEF5BkYBLxRuXAouExAFZTfbl3RMKhSqFJhdaKbfVrr1uIyV2sBNQfw1_lRnbSWshcYrkHce2vnnv7Awh77VUAXfzYnCtTSzSwGKfDJI4yDDwLgOfIWsKZKdqfCG-zeSsS7jVXVnlVic2ijorU8yRHzGpmREJsOOn1c8Yp0bh7mo3QuMuuSc4F8jnyewm4GKmHWorIFICwyq2h2a0OqpBdyd4NhmCaQYxQCx7hqnp3_-vlr5lpvollLds0skjst85k3TUov-Y3AnFE3J_0m2XPyV_TrtmEKDSqOvaj9Ayp9iZdRni3_Ms0C_TEcU50tdtVRzQZRQTCIsQF9jsuFwj1apcXC9LAGVeL-k8a2uMQkZHxz8mkrqaOlpvVk1VbVnhI0DpeVfRxfzSYQJys6T5wv2CnyuIfKt1VQK-z8jFydfz43HcTWSIU6n4Os7zgcokBI0ZxFnCA75SK29CIpmTxgWvfT4MjMs0V8lQprxpb4Y5Ez10qZD8OdkryiK8JDTnAbUJeGthKFJvjBCc6WzA4F-44j4iH7dw2FXbeMM2AYtWtgXPAni2Ac_KiHxGxHaU2DS7uVBWl7aTQbhdcWGGPGceeMWBa6ydMFrl4OIEeHZEPiDeFkUbQE1dd0IBXhibZNkRGHZwmYxKInLYowSRTPvLW46xnUqo7Q0DR-TdbhnvxDK3IpQbpAH9qbQRLCIvWgbbfRIX0nBw7iOS9Fiv9839lWJ-1TQM1wKCSMMP_v9ab8mD8fnkzJ6dTr-_Ig9ZIxtYGHNI9tbVJrwG72vt3zQi9hdOrivN |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSBMv3BmBAUZC4gGlF98SP5aOaQNaTYJJEy-WnThbRJNUaQoaf4a_yrGTVC287alSfdzU8ufjc5zP30HobcyFdW_zQgitZcgSS0ITjaLQcjsyOoWYIfUE2bk4OWefLvjFVqkvT9pPTD4oF8WgzK88t3JZJMOeJzY8m01jBkGxpMNlmg1vozuwZknUJ-pdrkVkW8-WQZIEeyrr78vEYrgCtx25a8mQRxMI_0NXvYYyLunIVf3e2p68iv__vnprs9olUm7tTMf30fd-TC0h5cdg3ZhB8vsfuccbDfoButfFq3jSmjxEt2z5CO3Pujfyj9Gf005vArwm1p3CCa4y7MRfCxv-ylOLj-YT7EpVX7fEO7BLsTujWNiwdHrKVeOsltXiuqhg3vNVgfO0pTHZFE-mX2cc6xXWeLVeeuJuVbtHgF81usaL_FK7M851gbOF_gkfV5Bc101dAYSeoPPjj9-mJ2FX9CFMuKBNmGUjkXLIS1NI5ZgBCPFYGGkjTjSX2prYZGNLKE8yEY15Qr2CmjuWicc6YZw-RXtlVdpnCGfUOocFAaEds8RIyRglcToi8CtUUBOg9_1cq2Wr7aF8ThQL1YJEAUiUB4niAfrg4LCxdLrc_ouqvlTdREF3QZkc04wYyqiG6DvWTMYigyjKwrMD9M6BSTnvAYhJdHcJAv6w0-FSE4gdICqTIgrQ4Y4lrPpkt7mHo-q8zkoRHhPJInDZAXqzaXY9HZOutNXa2YCLFrFkJEAHLXo3Q-oXQYCiHVzvjHm3BdDqNck7dD6_cc_XaP_s6Fh9OZ1_foHuEr86HSvnEO019dq-hNCvMa_8Iv8LoHFWaQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Integrative+analysis+of+genome-wide+DNA+methylation+and+single-nucleotide+polymorphism+identified+ACSM5+as+a+suppressor+of+lumbar+ligamentum+flavum+hypertrophy&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Cao%2C+Yanlin&rft.au=Zhan%2C+Yenan&rft.au=Qiu%2C+Sujun&rft.au=Chen%2C+Zhong&rft.date=2021-09-30&rft.pub=BioMed+Central&rft.issn=1478-6354&rft.eissn=1478-6362&rft.volume=23&rft.spage=1&rft_id=info:doi/10.1186%2Fs13075-021-02625-5 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon |